Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumorigenicity risk of iPSCs <i>in vivo</i>: nip it in the bud

3 Feb 2022

Abstract excerpt

In 2006, Takahashi and Yamanaka first created induced pluripotent stem cells from mouse fibroblasts via the retroviral introduction of genes encoding the transcription factors Oct3/4, Sox2, Klf44, and c-Myc. Since then, the future clinical application of somatic cell reprogramming technology has become an attractive research topic in the field of regenerative medicine. Of note, considerable interest has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35692443
DOI: 10.1093/pcmedi/pbac004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumorigenicity risk of iPSCs <i>in vivo</i>: nip it in the budPMID 35692443Read ↗

Ensuring Safety in Stem Cell Therapies: A Review of Tumorigenic Risks and Mitigation StrategiesSemantic proximity Read ↗

Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical PerspectivesSemantic proximity Read ↗

[Progress in the tumorigenic potential of iPSCs and methods to reduce it].Semantic proximity Read ↗

Induced pluripotent stem cells: opportunities and challengesSemantic proximity Read ↗

Immunogenicity and Tumorigenicity of Pluripotent Stem Cells and their Derivatives: Genetic and Epigenetic PerspectivesSemantic proximity Read ↗

The safety of human pluripotent stem cells in clinical treatmentSemantic proximity Read ↗

Ethical and Safety Issues of Stem Cell-Based TherapySemantic proximity Read ↗

Stem cell manipulation, gene therapy and the risk of cancer stem cell emergenceSemantic proximity Read ↗

Prospects of Induced Pluripotent Stem Cell Technology in Regenerative MedicineSemantic proximity Read ↗

Technological Overview of iPS Induction from Human Adult Somatic CellsSemantic proximity Read ↗

Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discoverySemantic proximity Read ↗

Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe applicationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.